| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:731.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the School of Population Health, University of Western Australia, Perth, Australia (K.H., K.J., R.J.B.); Stroke Unit, Department of Neurology, Royal Perth Hospital, and Department of Medicine, University of Western Australia (G.J.H.); Imperial College of Science, Technology and Medicine, London, UK (K.J.); and Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand (C.A.).
Correspondence to Professor Graeme J. Hankey, Consultant Neurologist and Head of Stroke Unit, Department of Neurology, Royal Perth Hospital, GPO Box X2213, Perth, Western Australia 6001. E-mail gjhankey{at}cyllene.uwa.edu.au
Background and Purpose Limited information exists on the long-term prognosis after first-ever stroke. We aimed to determine the absolute frequency of first recurrent stroke and disability and the relative frequency of recurrent stroke over 10 years after first-ever stroke in Perth, Western Australia.
Methods For a 12-month period beginning February 1989, all individuals with suspected acute stroke or transient ischemic attack who lived in a geographically defined and representative region of Perth were registered prospectively. Patients with a definite first-ever stroke were followed up 10 years after the index event.
Results Over 10 years of follow-up, the cumulative risk of a first recurrent stroke was 43% (95% confidence interval [CI], 34 to 51). After the first year after first-ever stroke, the average annual risk of recurrent stroke was
4%. Case fatality at 30 days after first recurrent stroke was 41%, which was significantly greater than the case fatality at 30 days after first-ever stroke (22%) (P=0.003). For 30-day survivors of first-ever stroke, the 10-year cumulative risk of death or new institutionalization was 79% (95% CI, 73 to 85) and of death or new disability was 87% (95% CI, 81 to 92).
Conclusions Over 10 years of follow-up, the risk of first recurrent stroke is 6 times greater than the risk of first-ever stroke in the general population of the same age and sex, almost one half of survivors remain disabled, and one seventh require institutional care. Effective strategies for prevention of stroke need to be implemented early, monitored frequently, and maintained long term after first-ever stroke.
Key Words: Australia cerebrovascular accident epidemiology morbidity
This article has been cited by other articles:
![]() |
K M Mohan, S L Crichton, A P Grieve, A G Rudd, C D A Wolfe, and P U Heuschmann Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 1012 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pezzini, M. Grassi, E. Del Zotto, C. Lodigiani, P. Ferrazzi, A. Spalloni, R. Patella, A. Giossi, I. Volonghi, L. Iacoviello, et al. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults Neurology, September 1, 2009; 73(9): 717 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cadilhac, R. Carter, A. G. Thrift, and H. M. Dewey Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for Australia: New Evidence Derived From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, March 1, 2009; 40(3): 915 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pettersen, Y. Haig, P. H. Nakstad, and T. B. Wyller Subtypes of urinary incontinence after stroke: relation to size and location of cerebrovascular damage Age Ageing, May 1, 2008; 37(3): 324 - 327. [Full Text] [PDF] |
||||
![]() |
S. G. Passero and S. Rossi Natural history of vertebrobasilar dolichoectasia Neurology, January 1, 2008; 70(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hankey, J. Spiesser, Z. Hakimi, G. Bego, P. Carita, and S. Gabriel Rate, degree, and predictors of recovery from disability following ischemic stroke Neurology, May 8, 2007; 68(19): 1583 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Kikano and M. T. Brown Antiplatelet Therapy for Atherothrombotic Disease: An Update for the Primary Care Physician Mayo Clin. Proc., May 1, 2007; 82(5): 583 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hankey, J. Spiesser, Z. Hakimi, P. Carita, and S. Gabriel Time frame and predictors of recovery from disability following recurrent ischemic stroke Neurology, January 16, 2007; 68(3): 202 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
I van Wijk, E Lindeman, L J Kappelle, J van Gijn, P J Koudstaal, J W Gorter, A Algra, and for the LiLAC Study Group* Functional status and use of healthcare facilities in long-term survivors of transient ischaemic attack or minor ischaemic stroke J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1238 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele and S. R. Levine Addressing racial and ethnic disparities in stroke: The time is now Neurology, October 24, 2006; 67(8): 1328 - 1329. [Full Text] [PDF] |
||||
![]() |
F. Dentali, M. Gianni, M. A. Crowther, and W. Ageno Natural history of cerebral vein thrombosis: a systematic review Blood, August 15, 2006; 108(4): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Stroke Prevention by Aggressive Reduction in C High-Dose Atorvastatin after Stroke or Transient Ischemic Attack N. Engl. J. Med., August 10, 2006; 355(6): 549 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chaturvedi and J. S. Yadav The Role of Antiplatelet Therapy in Carotid Stenting for Ischemic Stroke Prevention Stroke, June 1, 2006; 37(6): 1572 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Pang, J. J Eng, A. S Dawson, and S. Gylfadottir The use of aerobic exercise training in improving aerobic capacity in individuals with stroke: a meta-analysis Clinical Rehabilitation, February 1, 2006; 20(2): 97 - 111. [Abstract] [PDF] |
||||
![]() |
D. J. Campbell, M. Woodward, J. P. Chalmers, S. A. Colman, A. J. Jenkins, B. E. Kemp, B. C. Neal, A. Patel, and S. W. MacMahon Soluble Vascular Cell Adhesion Molecule 1 and N-terminal Pro-B-Type Natriuretic Peptide in Predicting Ischemic Stroke in Patients With Cerebrovascular Disease Arch Neurol, January 1, 2006; 63(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patel, M. Woodward, D. J. Campbell, D. R. Sullivan, S. Colman, J. Chalmers, B. Neal, and S. MacMahon Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease Eur. Heart J., September 2, 2005; 26(18): 1910 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele, J. L. Saver, A. Fredieu, S. Suzuki, S. Selco, V. Rajajee, N. McNair, T. Razinia, and C. S. Kidwell In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up Stroke, December 1, 2004; 35(12): 2879 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
23 Apr 2004 to 23 Jul 2004 Evid. Based Nurs., October 1, 2004; 7(4): e4 - e4. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., September 1, 2004; 9(5): 159 - 160. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |